Think Research Corporation (THKKF)
| Previous Close | 0.3601 |
| Open | 0.4000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.3601 - 0.3601 |
| 52 Week Range | 0.2185 - 1.0000 |
| Volume | |
| Avg. Volume | 561 |
| Market Cap | 25.962M |
| Beta (5Y Monthly) | 0.74 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3300 |
| Earnings Date | May 01, 2023 - May 05, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Think Research Selected For a 5-year SaaS Agreement to Help Address Urgent Patient Access Challenges
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, is pleased to announce, its support for the new client to improve access to quality, timely healthcare.
- CNW Group
Think Research Announces $3.5 Million Contract Expansion with a Global Pharmaceutical Company
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, is pleased to announce that it has expanded its original $6.4 million contract announced on September 8, 2022, with a global pharmaceutical company by approximately $3.5 million, bringing the total value up to approximately $10 million.
- CNW Group
Think Research Secures Contract to Deliver Essential Data and Services Platform to New Customer
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, today announced that it entered into an agreement with a new customer on January 30, 2023, to provide a broad range of software solutions, data and subscription services to help improve access to quality healthcare. The value of this engagement is approximately $2.0 million.
